• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对非缺血性心肌病和室性心动过速患者的整个人心肌组织学进行验证,以实现电解剖电压标测。

Whole human heart histology to validate electroanatomical voltage mapping in patients with non-ischaemic cardiomyopathy and ventricular tachycardia.

机构信息

Department of Cardiology, Leiden University Medical Centre, Albinusdreef 2, 2333ZA Leiden, The Netherlands.

LKEB-Division of Image Processing, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

Eur Heart J. 2018 Aug 14;39(31):2867-2875. doi: 10.1093/eurheartj/ehy168.

DOI:10.1093/eurheartj/ehy168
PMID:29617764
Abstract

AIMS

Electroanatomical voltage mapping (EAVM) is an important diagnostic tool for fibrosis identification and risk stratification in non-ischaemic cardiomyopathy (NICM); currently, distinct cut-offs are applied. We aimed to evaluate the performance of EAVM to detect fibrosis by integration with whole heart histology and to identify the fibrosis pattern in NICM patients with ventricular tachycardias (VTs).

METHODS AND RESULTS

Eight patients with NICM and VT underwent EAVM prior to death or heart transplantation. EAVM data was projected onto slices of the entire heart. Pattern, architecture, and amount of fibrosis were assessed in transmural biopsies corresponding to EAVM sites. Fibrosis pattern in NICM biopsies (n = 507) was highly variable and not limited to mid-wall/sub-epicardium. Fibrosis architecture was rarely compact, but typically patchy and/or diffuse. In NICM, biopsies without abnormal fibrosis unipolar voltage (UV) and bipolar voltage (BV) showed a linear association with wall thickness (WT). The amount of viable myocardium showed a linear association with both UV and BV. Accordingly, any cut-off to delineate fibrosis performed poorly. An equation was generated calculating the amount of fibrosis at any location, given WT and UV or BV.

CONCLUSION

Considering the linear relationships between WT, amount of fibrosis and both UV and BV, the search for any distinct voltage cut-off to identify fibrosis in NICM is futile. The amount of fibrosis can be calculated, if WT and voltages are known. Fibrosis pattern and architecture are different from ischaemic cardiomyopathy and findings on ischaemic substrates may not be applicable to NICM.

摘要

目的

电解剖电压测绘(EAVM)是识别非缺血性心肌病(NICM)纤维化和风险分层的重要诊断工具;目前,应用了不同的截断值。我们旨在通过整合全心组织学评估 EAVM 检测纤维化的性能,并确定伴有室性心动过速(VTs)的 NICM 患者的纤维化模式。

方法和结果

8 例 NICM 合并 VT 的患者在死亡或心脏移植前行 EAVM。EAVM 数据被投影到整个心脏的切片上。在与 EAVM 部位相对应的穿透性活检中评估纤维化的模式、结构和数量。NICM 活检(n=507)中的纤维化模式变化多样,不限于中壁/心外膜。纤维化结构很少是致密的,但通常是斑片状和/或弥漫性的。在 NICM 中,无异常纤维化的单极电压(UV)和双极电压(BV)活检与壁厚度(WT)呈线性相关。存活心肌的数量与 UV 和 BV 均呈线性相关。因此,任何用于界定纤维化的截断值都表现不佳。生成了一个方程,用于计算在任何位置的纤维化量,给定 WT 和 UV 或 BV。

结论

考虑到 WT、纤维化量以及 UV 和 BV 之间的线性关系,寻找任何明确的电压截断值来识别 NICM 中的纤维化都是徒劳的。如果知道 WT 和电压,则可以计算纤维化的量。纤维化模式和结构与缺血性心肌病不同,缺血性基质上的发现可能不适用于 NICM。

相似文献

1
Whole human heart histology to validate electroanatomical voltage mapping in patients with non-ischaemic cardiomyopathy and ventricular tachycardia.对非缺血性心肌病和室性心动过速患者的整个人心肌组织学进行验证,以实现电解剖电压标测。
Eur Heart J. 2018 Aug 14;39(31):2867-2875. doi: 10.1093/eurheartj/ehy168.
2
Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging.非缺血性心肌病患者室性心动过速消融的心脏外膜基质标测:通过同时整合计算机断层扫描和对比增强磁共振成像开发的一种新算法,以区分疤痕组织和存活心肌。
Eur Heart J. 2013 Feb;34(8):586-96. doi: 10.1093/eurheartj/ehs382. Epub 2012 Nov 15.
3
Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications.非缺血性扩张型心肌病患者室性心动过速的孤立性间隔基质:发生率、特征及意义。
Heart Rhythm. 2011 Aug;8(8):1169-76. doi: 10.1016/j.hrthm.2011.03.008. Epub 2011 Mar 8.
4
Periaortic Ventricular Tachycardias in Nonischemic Cardiomyopathy: Substrate and Electrocardiographic Correlations.非缺血性心肌病患者的心包周室性心动过速:基质与心电图相关性。
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e008887. doi: 10.1161/CIRCEP.120.008887. Epub 2021 Jan 8.
5
Sinus rhythm QRS amplitude and fractionation in patients with nonischemic cardiomyopathy to identify ventricular tachycardia substrate and location.非缺血性心肌病患者窦性心律 QRS 波振幅和碎裂识别室性心动过速的基质和部位。
Heart Rhythm. 2022 Feb;19(2):187-194. doi: 10.1016/j.hrthm.2021.09.028. Epub 2021 Sep 30.
6
Unipolar Endocardial Voltage Mapping in the Right Ventricle: Optimal Cutoff Values Correcting for Computed Tomography-Derived Epicardial Fat Thickness and Their Clinical Value for Substrate Delineation.右心室单极心内膜电压标测:校正计算机断层扫描衍生的心外膜脂肪厚度的最佳截断值及其在基质描绘中的临床价值。
Circ Arrhythm Electrophysiol. 2017 Aug;10(8). doi: 10.1161/CIRCEP.117.005175.
7
CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.基于 CMR 的缺血性和非缺血性室性心动过速关键峡部部位的识别。
JACC Cardiovasc Imaging. 2014 Aug;7(8):774-84. doi: 10.1016/j.jcmg.2014.03.013. Epub 2014 Jul 16.
8
Multisize Electrodes for Substrate Identification in Ischemic Cardiomyopathy: Validation by Integration of Whole Heart Histology.多尺寸电极用于缺血性心肌病中的底物识别:通过整合全心组织学进行验证。
JACC Clin Electrophysiol. 2019 Oct;5(10):1130-1140. doi: 10.1016/j.jacep.2019.06.004. Epub 2019 Jul 31.
9
Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches.非缺血性心肌病室性心动过速的导管消融:心内膜、心外膜和壁内途径
Heart Lung Circ. 2019 Jan;28(1):84-101. doi: 10.1016/j.hlc.2018.10.007. Epub 2018 Oct 19.
10
Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?通过磁共振成像可视化的心外膜室性心动过速基质:是否需要经心包消融方法?
Clin Res Cardiol. 2016 Oct;105(10):827-37. doi: 10.1007/s00392-016-0990-0. Epub 2016 Jun 13.

引用本文的文献

1
Myocardial characterization using late enhancement photon-counting detector CT in ventricular arrhythmia: comparison with electroanatomical mapping.使用晚期强化光子计数探测器CT对室性心律失常进行心肌特征分析:与电解剖标测的比较。
Insights Imaging. 2025 Aug 29;16(1):187. doi: 10.1186/s13244-025-02069-4.
2
Preprocedural Substrate Visualization and Image Integration Based on Late Enhancement Computed Tomography for Ventricular Tachycardia Ablation in Non-Ischemic Cardiomyopathy.基于延迟强化计算机断层扫描的非缺血性心肌病室性心动过速消融术前基质可视化与图像整合
J Clin Med. 2025 Aug 16;14(16):5801. doi: 10.3390/jcm14165801.
3
Ventricular Tachycardia Predicts All-Cause Mortality and Nonsudden Cardiac Death in Nonischemic Cardiomyopathy.
室性心动过速可预测非缺血性心肌病的全因死亡率和非心源性猝死。
JACC Adv. 2025 Aug 13;4(9):102063. doi: 10.1016/j.jacadv.2025.102063.
4
Cardiac CT for electrophysiological interventions.用于电生理干预的心脏CT
Int J Cardiovasc Imaging. 2025 May 27. doi: 10.1007/s10554-025-03397-8.
5
Epicardial ventricular arrhythmia ablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.心外膜室性心律失常消融:欧洲心脏病学会欧洲心律协会、心律协会、亚太心律协会、拉丁美洲心律协会及加拿大心律协会的临床共识声明
Europace. 2025 Mar 28;27(4). doi: 10.1093/europace/euaf055.
6
Late gadolinium enhancement imaging for the prediction of ventricular tachycardia ablation outcome.钆延迟强化成像预测室性心动过速消融结果
J Interv Card Electrophysiol. 2025 Feb 21. doi: 10.1007/s10840-025-02017-8.
7
[Role of ventricular tachycardia ablation in patients with systolic heart failure].[室性心动过速消融在收缩性心力衰竭患者中的作用]
Herzschrittmacherther Elektrophysiol. 2025 Mar;36(1):10-20. doi: 10.1007/s00399-024-01064-4. Epub 2025 Jan 22.
8
Echocardiographic Predictors of Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices and Implantable Cardioverter-Defibrillator.左心室辅助装置和植入式心脏复律除颤器患者室性心律失常的超声心动图预测指标
J Cardiovasc Electrophysiol. 2025 Feb;36(2):387-395. doi: 10.1111/jce.16539. Epub 2024 Dec 16.
9
Optimizing ventricular tachycardia ablation through imaging-based assessment of arrhythmic substrate: A comprehensive review and roadmap for the future.通过基于成像的心律失常基质评估优化室性心动过速消融:全面综述与未来路线图
Heart Rhythm O2. 2024 Jul 5;5(8):561-572. doi: 10.1016/j.hroo.2024.07.001. eCollection 2024 Aug.
10
Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society.立体定向心律失常射频消融的患者选择、室性心动过速基质描绘及数据传输:欧洲心脏病学会欧洲心律协会和心律协会的临床共识声明
Europace. 2025 Mar 28;27(4). doi: 10.1093/europace/euae214.